Novartis Bioventures Ltd
CIK 0001297709 Name as filed on the most recent filing
Filed as Novartis Bioventures Ltd (61)
188 transaction lines · from 61 filings · filed 2011-01-21 to 2020-07-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER Akouos, Inc. 1 filings
- ISSUER Galera Therapeutics, Inc. 6 filings
- ISSUER Bicycle Therapeutics plc 1 filings
- ISSUER Aerpio Pharmaceuticals, Inc. 9 filings
- ISSUER Aileron Therapeutics Inc 15 filings
- ISSUER Aeglea BioTherapeutics, Inc. 4 filings
- ISSUER Ra Pharmaceuticals, Inc. 11 filings
- ISSUER Proteostasis Therapeutics, Inc. 1 filings
- ISSUER Tokai Pharmaceuticals Inc 7 filings
- ISSUER Akebia Therapeutics, Inc. 1 filings
- ISSUER Celladon Corp 1 filings
- ISSUER Marina Biotech, Inc. 4 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
2 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2020-06-30 |
Akouos, Inc. AKUS |
P, Open-market purchase | 125,000 acquired | 17.00 | 2,125,000.00 | Form 4, filing 0001104659-20-080559 | |
| 2020-06-19 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 1,001,312 disposed | 8.25 | 8,260,824.00 | Form 4, filing 0000925421-20-000256 | |
| 2020-06-18 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 900 disposed | 9.04 | 8,136.00 | Form 4, filing 0000925421-20-000256 | |
| 2020-06-17 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 4,622 disposed | 9.27 | 42,845.94 | Form 4, filing 0000925421-20-000254 | |
| 2020-06-16 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 8,600 disposed | 9.30 | 79,980.00 | Form 4, filing 0000925421-20-000254 | |
| 2020-06-15 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 6,164 disposed | 9.05 | 55,784.20 | Form 4, filing 0000925421-20-000254 | |
| 2020-06-12 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 1,500 disposed | 9.19 | 13,785.00 | Form 4, filing 0000925421-20-000248 | |
| 2020-06-11 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 7,200 disposed | 9.21 | 66,312.00 | Form 4, filing 0000925421-20-000248 | |
| 2020-06-10 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 8,532 disposed | 9.46 | 80,712.72 | Form 4, filing 0000925421-20-000248 | |
| 2020-06-09 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 7,000 disposed | 9.38 | 65,660.00 | Form 4, filing 0000925421-20-000244 | |
| 2020-06-08 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 5,659 disposed | 9.66 | 54,665.94 | Form 4, filing 0000925421-20-000244 | |
| 2020-06-05 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 8,652 disposed | 9.66 | 83,578.32 | Form 4, filing 0000925421-20-000244 | |
| 2020-06-04 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 4,088 disposed | 9.55 | 39,040.40 | Form 4, filing 0000925421-20-000228 | |
| 2020-06-03 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 5,208 disposed | 9.78 | 50,934.24 | Form 4, filing 0000925421-20-000228 | |
| 2020-06-02 |
Galera Therapeutics, Inc. GRTX |
S, Open-market sale | 5,669 disposed | 9.68 | 54,875.92 | Form 4, filing 0000925421-20-000228 | |
| 2019-11-12 |
Galera Therapeutics, Inc. GRTX |
P, Open-market purchase | 250,000 acquired | 12.00 | 3,000,000.00 | Form 4, filing 0000899243-19-027115 | |
| 2019-05-28 |
Bicycle Therapeutics plc BCYC |
P, Open-market purchase | 168,630 acquired | 14.00 | 2,360,820.00 | Form 4, filing 0001104659-19-032920 | |
| 2019-04-26 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 138,704 disposed | 1.03 | 142,865.12 | Form 4, filing 0000925421-19-000179 | |
| 2019-04-25 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 563,096 disposed | 1.03 | 579,988.88 | Form 4, filing 0000925421-19-000179 | |
| 2019-04-24 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 16,403 disposed | 1.03 | 16,895.09 | Form 4, filing 0000925421-19-000157 | |
| 2019-04-23 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 27,554 disposed | 1.03 | 28,380.62 | Form 4, filing 0000925421-19-000157 | |
| 2019-04-22 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 7,100 disposed | 0.97 | 6,887.00 | Form 4, filing 0000925421-19-000157 | |
| 2019-04-15 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 28,794 disposed | 0.99 | 28,506.06 | Form 4, filing 0000925421-19-000153 | |
| 2019-04-12 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 30,908 disposed | 1.04 | 32,144.32 | Form 4, filing 0000925421-19-000153 | |
| 2019-04-11 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 57,438 disposed | 1.08 | 62,033.04 | Form 4, filing 0000925421-19-000153 | |
| 2019-04-10 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 140,230 disposed | 1.09 | 152,850.70 | Form 4, filing 0000925421-19-000149 | |
| 2019-04-09 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 32,991 disposed | 1.01 | 33,320.91 | Form 4, filing 0000925421-19-000149 | |
| 2019-04-08 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 27,525 disposed | 1.02 | 28,075.50 | Form 4, filing 0000925421-19-000149 | |
| 2019-04-05 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 24,661 disposed | 1.02 | 25,154.22 | Form 4, filing 0000925421-19-000145 | |
| 2019-04-04 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 47,900 disposed | 1.01 | 48,379.00 | Form 4, filing 0000925421-19-000145 | |
| 2019-04-03 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 58,033 disposed | 0.96 | 55,711.68 | Form 4, filing 0000925421-19-000145 | |
| 2019-04-02 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 51,754 disposed | 0.97 | 50,201.38 | Form 4, filing 0000925421-19-000141 | |
| 2019-04-01 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 20,610 disposed | 1.90 | 39,159.00 | Form 4, filing 0000925421-19-000143 | |
| 2019-04-01 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 116,909 disposed | 0.95 | 111,063.55 | Form 4, filing 0000925421-19-000141 | |
| 2019-03-29 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 106,540 disposed | 1.85 | 197,099.00 | Form 4, filing 0000925421-19-000143 | |
| 2019-03-29 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 63,100 disposed | 0.91 | 57,421.00 | Form 4, filing 0000925421-19-000141 | |
| 2019-03-28 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 88,835 disposed | 0.94 | 83,504.90 | Form 4, filing 0000925421-19-000139 | |
| 2019-03-27 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 50,749 disposed | 0.99 | 50,241.51 | Form 4, filing 0000925421-19-000139 | |
| 2019-03-26 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 177,762 disposed | 1.01 | 179,539.62 | Form 4, filing 0000925421-19-000139 | |
| 2019-03-15 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 43,800 disposed | 1.92 | 84,096.00 | Form 4, filing 0000925421-19-000114 | |
| 2019-03-14 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 13,800 disposed | 1.88 | 25,944.00 | Form 4, filing 0000925421-19-000114 | |
| 2019-03-13 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 132,738 disposed | 2.12 | 281,404.56 | Form 4, filing 0000925421-19-000114 | |
| 2018-08-20 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 20,388 disposed | 2.30 | 46,892.40 | Form 4, filing 0000925421-18-000300 | |
| 2018-08-20 |
Aerpio Pharmaceuticals, Inc. ARPO |
S, Open-market sale | 5,300 disposed | 3.90 | 20,670.00 | Form 4, filing 0000925421-18-000298 | |
| 2018-08-17 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 8,700 disposed | 2.10 | 18,270.00 | Form 4, filing 0000925421-18-000294 | |
| 2018-08-16 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 8,808 disposed | 2.10 | 18,496.80 | Form 4, filing 0000925421-18-000294 | |
| 2018-08-15 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 2,635 disposed | 2.15 | 5,665.25 | Form 4, filing 0000925421-18-000292 | |
| 2018-08-14 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 3,300 disposed | 2.26 | 7,458.00 | Form 4, filing 0000925421-18-000292 | |
| 2018-08-13 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 1,600 disposed | 2.36 | 3,776.00 | Form 4, filing 0000925421-18-000290 | |
| 2018-08-10 |
Aileron Therapeutics Inc ALRN |
S, Open-market sale | 5,615 disposed | 2.44 | 13,700.60 | Form 4, filing 0000925421-18-000290 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 2
- Open-market sale 0
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Novartis Bioventures Ltd, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001297709
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6